These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7727127

  • 1. Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting.
    Blaszyk H, Hartmann A, Schroeder JJ, McGovern RM, Sommer SS, Kovach JS.
    Biotechniques; 1995 Feb; 18(2):256-60. PubMed ID: 7727127
    [Abstract] [Full Text] [Related]

  • 2. Highly sensitive mutation screening by REF with low concentrations of urea: A blinded analysis of a 2-kb region of the p53 gene reveals two common haplotypes.
    Feng J, Buzin CH, Tang SH, Scaringe WA, Sommer SS.
    Hum Mutat; 1999 Feb; 14(2):175-80. PubMed ID: 10425040
    [Abstract] [Full Text] [Related]

  • 3. Dideoxy fingerprinting assay for BRCA1 mutation analysis.
    Lancaster JM, Berchuck A, Futreal PA, Wiseman RW.
    Mol Carcinog; 1997 Jul; 19(3):176-9. PubMed ID: 9254884
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved detection of p53 point mutations by dideoxyfingerprinting (ddF).
    Martincic D, Whitlock JA.
    Oncogene; 1996 Nov 07; 13(9):2039-44. PubMed ID: 8934553
    [Abstract] [Full Text] [Related]

  • 6. Detection of mutations and polymorphisms using fluorescence-based dideoxy fingerprinting (F-ddF).
    Ellison J, Squires G, Crutchfield C, Goldman D.
    Biotechniques; 1994 Oct 07; 17(4):742-3, 746-7, 748-53. PubMed ID: 7833039
    [Abstract] [Full Text] [Related]

  • 7. Alport syndrome. Molecular genetic aspects.
    Hertz JM.
    Dan Med Bull; 2009 Aug 07; 56(3):105-52. PubMed ID: 19728970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM, Noffsinger AE, Miller MA, DeVoe GW, Stemmermann GN, Macdonald JS, Fenoglio-Preiser CM.
    Mod Pathol; 1999 Jan 07; 12(1):54-60. PubMed ID: 9950163
    [Abstract] [Full Text] [Related]

  • 10. BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
    Kringen P, Egedal S, Pedersen JC, Harbitz TB, Tveit KM, Berg K, Børresen-Dale AL, Andersen TI.
    Electrophoresis; 2002 Dec 07; 23(24):4085-91. PubMed ID: 12481264
    [Abstract] [Full Text] [Related]

  • 11. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene.
    Moyret C, Theillet C, Puig PL, Molés JP, Thomas G, Hamelin R.
    Oncogene; 1994 Jun 07; 9(6):1739-43. PubMed ID: 8183571
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300-600 bp.
    Liu Q, Feng J, Sommer SS.
    Hum Mol Genet; 1996 Jan 07; 5(1):107-14. PubMed ID: 8789447
    [Abstract] [Full Text] [Related]

  • 16. Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis.
    Kutach LS, Bolshakov S, Ananthaswamy HN.
    Electrophoresis; 1999 Jun 07; 20(6):1204-10. PubMed ID: 10380760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA.
    Cancer Res; 1993 Apr 01; 53(7):1676-83. PubMed ID: 8453641
    [Abstract] [Full Text] [Related]

  • 19. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL, Dean RC, Zhang W, Young D, Sesterhenn IA, Shanmugam N, McLeod DG, Moul JW, Srivastava S.
    Prostate Cancer Prostatic Dis; 2003 Apr 01; 6(4):281-5. PubMed ID: 14663467
    [Abstract] [Full Text] [Related]

  • 20. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
    Soong R, Iacopetta BJ.
    Mod Pathol; 1997 Mar 01; 10(3):252-8. PubMed ID: 9071734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.